Caliper Life Sciences Inc. is a leading provider of cutting-edge technologies enabling researchers in the life sciences field to create medicines and diagnostic tests more quickly and efficiently. The company’s portfolio of products include state-of-the-art microfluidics, lab automation and liquid handling, optical imaging technologies and discovery & development outsourcing solutions.

The company announced today it has installed the 1000th IVIS preclinical imaging system, a milestone event in the rapid adoption of Caliper’s proprietary in vivo imaging solutions. The center for Advanced Molecular Imaging at Northwestern University purchased Caliper’s IVIS Spectrum to enable nano-particle technology research for the targeting of cancer tumors and non-invasive monitoring of tumor progression and therapeutic response in patients.

Caliper’s IVIS imaging technology is the leading tool in the rapidly growing field of preclinical non-invasive optical molecular imaging. The use of IVIS technology has assisted in the discovery and development of at least 13 compounds that have moved into clinical testing, 5 of which are FDA-approved treatments.

It is also gained rapid acceptance throughout the pharmaceutical and academic research communities. The company’s preclinical imaging solutions have been a key tool in the generation of more than 2,600 peer-reviewed publications. The research was conducted in a broad range of medical fields including cancer research, cardiovascular disease, toxicology, infectious diseases and stem cells.

For more information about Caliper Life Sciences, please visit the company’s website at www.caliperLS.com